{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:08:00Z","timestamp":1790035680463,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project.","award":["TJYXZDXK-3-024C"],"award-info":[{"award-number":["TJYXZDXK-3-024C"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Chemoresistance is a reason for treatment failure in prostate cancer. Receptor-interacting protein kinase 2 (RIPK2) has been shown to play a role in drug resistance in various cancers; however, its role and the underlying mechanism of chemoresistance in prostate cancer are unclear. We analyzed data from The Cancer Genome Atlas for RIPK2 expression in prostate cancer and its association with clinicopathological features. We also elucidated the role and mechanism of action of RIPK2 in prostate cancer cell resistance to docetaxel (DTX). The results showed that RIPK2 expression was upregulated in prostate cancer tissues and was associated with poor pathological grading. RIPK2 was also upregulated in 22RV1\/DTX, C4-2\/DTX, PC-3\/DTX, and DU145\/DTX cell lines and involved in DTX resistance. Mechanistic experiments revealed that RIPK2 was involved in DTX resistance by upregulating P-glycoprotein (P-gp) expression through the activation of the NF-\u03baB signaling pathway. Xenograft tumor experiments confirmed that inhibition of RIPK2 or P-gp enhanced the efficacy of DTX in suppressing PC-3\/DTX growth. Taken together, these results suggest that RIPK2 mediates DTX resistance in prostate cancer cells through the NF-\u03baB\/P-gp signaling pathway. RIPK2 and its downstream signaling molecules are potential targets for the treatment of chemoresistant prostate cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0341445","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:31:57Z","timestamp":1769020317000},"page":"e0341445","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["RIPK2 induces docetaxel resistance in prostate cancer through the NF-\u03baB\/P-gp signaling pathway"],"prefix":"10.1371","volume":"21","author":[{"given":"Shaoqiang","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4743-4713","authenticated-orcid":true,"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"2","key":"pone.0341445.ref001","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"W Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"pone.0341445.ref002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"C Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"17","key":"pone.0341445.ref003","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches","volume":"27","author":"M Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"10","key":"pone.0341445.ref004","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"EM Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"pone.0341445.ref005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced Prostate Cancer: Treatment Advances and Future Directions","volume":"6","author":"U Swami","year":"2020","journal-title":"Trends Cancer"},{"issue":"3","key":"pone.0341445.ref006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOU.0000000000000985","article-title":"The role of chemotherapy in metastatic prostate cancer","volume":"32","author":"IB Riaz","year":"2022","journal-title":"Curr Opin Urol"},{"issue":"11","key":"pone.0341445.ref007","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/IAI.05641-11","article-title":"Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A","volume":"79","author":"T Balamayooran","year":"2011","journal-title":"Infect Immun"},{"issue":"2","key":"pone.0341445.ref008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/imm.12307","article-title":"Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils","volume":"143","author":"Y-J Jeong","year":"2014","journal-title":"Immunology"},{"key":"pone.0341445.ref009","doi-asserted-by":"crossref","first-page":"8537381","DOI":"10.1155\/2020\/8537381","article-title":"Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA","volume":"2020","author":"X Li","year":"2020","journal-title":"Biomed Res Int"},{"issue":"14","key":"pone.0341445.ref010","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.18632\/aging.204195","article-title":"The RIPK family: expression profile and prognostic value in lung adenocarcinoma","volume":"14","author":"G Li","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"pone.0341445.ref011","doi-asserted-by":"crossref","first-page":"10450","DOI":"10.18632\/aging.202808","article-title":"RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma","volume":"13","author":"D Li","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"pone.0341445.ref012","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/medicina57070709","article-title":"Receptor-Interacting Serine\/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer","volume":"57","author":"RF Jaafar","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"pone.0341445.ref013","doi-asserted-by":"crossref","first-page":"113644","DOI":"10.1016\/j.yexcr.2023.113644","article-title":"RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG","volume":"429","author":"Z Zhang","year":"2023","journal-title":"Exp Cell Res"},{"key":"pone.0341445.ref014","doi-asserted-by":"crossref","first-page":"627464","DOI":"10.3389\/fgene.2021.627464","article-title":"Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-\u03baB Signaling Pathway in Gastric Cancer","volume":"12","author":"Q Yang","year":"2021","journal-title":"Front Genet"},{"issue":"2","key":"pone.0341445.ref015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00418-021-02055-z","article-title":"Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-\u03baB pathway","volume":"157","author":"W Zhang","year":"2022","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"pone.0341445.ref016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10020-023-00648-z","article-title":"Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-\u03baB\/JNK\/ERK phosphorylation","volume":"29","author":"J Jiao","year":"2023","journal-title":"Mol Med"},{"issue":"2","key":"pone.0341445.ref017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2159-8290.CD-23-0584","article-title":"Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer","volume":"14","author":"W Sang","year":"2024","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0341445.ref018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13048-022-00986-2","article-title":"High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer","volume":"15","author":"Y Shen","year":"2022","journal-title":"J Ovarian Res"},{"issue":"12","key":"pone.0341445.ref019","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/cns.13981","article-title":"Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance","volume":"28","author":"X-L Wang","year":"2022","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"pone.0341445.ref020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41467-022-28340-6","article-title":"Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis","volume":"13","author":"Y Yan","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0341445.ref021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","article-title":"Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies","volume":"59","author":"M Elmeliegy","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"pone.0341445.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301345","article-title":"Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and Ferroptosis","volume":"13","author":"Y Guan","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"pone.0341445.ref023","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2022.01.014","article-title":"Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1\/RIPK2\/NF-\u03baB pathway","volume":"530","author":"D Nomoto","year":"2022","journal-title":"Cancer Lett"},{"issue":"1","key":"pone.0341445.ref024","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7150\/jca.90008","article-title":"Receptor-interacting protein kinase 2 is associated with tumor immune infiltration, immunotherapy-related biomarkers, and affects gastric cancer cells growth in vivo","volume":"15","author":"Q Yang","year":"2024","journal-title":"J Cancer"},{"issue":"1","key":"pone.0341445.ref025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10020-022-00475-8","article-title":"Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction","volume":"28","author":"J Song","year":"2022","journal-title":"Mol Med"},{"issue":"7","key":"pone.0341445.ref026","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/jcp.30759","article-title":"NF-\u03baB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition","volume":"237","author":"S Mirzaei","year":"2022","journal-title":"J Cell Physiol"},{"issue":"2","key":"pone.0341445.ref027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/genes15020197","article-title":"NF-\u03baB: Governing Macrophages in Cancer","volume":"15","author":"J Cornice","year":"2024","journal-title":"Genes (Basel)"},{"issue":"11","key":"pone.0341445.ref028","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1242\/jcs.183889","article-title":"PAX5 interacts with RIP2 to promote NF-\u03baB activation and drug-resistance in B-lymphoproliferative disorders","volume":"129","author":"D Wang","year":"2016","journal-title":"J Cell Sci"},{"issue":"6","key":"pone.0341445.ref029","first-page":"2915","article-title":"RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NF\u2011\u03baB and p38 signaling pathways","volume":"39","author":"X Cai","year":"2018","journal-title":"Oncol Rep"},{"key":"pone.0341445.ref030","doi-asserted-by":"crossref","first-page":"105835","DOI":"10.1016\/j.jsbmb.2021.105835","article-title":"\u03b3-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the \u03b3-Tocotrienol-NF-\u03baB-P-gp axis","volume":"209","author":"Y Ding","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"21","key":"pone.0341445.ref031","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1021\/acs.jmedchem.2c01175","article-title":"New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells","volume":"65","author":"L Braconi","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"pone.0341445.ref032","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21739","article-title":"Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)","volume":"41","year":"2021","journal-title":"Med Res Rev"},{"issue":"8","key":"pone.0341445.ref033","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/1061186X.2022.2069782","article-title":"Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy","volume":"30","author":"S Md","year":"2022","journal-title":"J Drug Target"},{"issue":"10","key":"pone.0341445.ref034","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/md20100597","article-title":"Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer Cells","volume":"20","author":"SA Dyshlovoy","year":"2022","journal-title":"Mar Drugs"},{"issue":"1","key":"pone.0341445.ref035","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1038\/s41598-022-17447-x","article-title":"New diterpenes from the marine sponge Spongionella sp. overcome drug resistance in prostate cancer by inhibition of P-glycoprotein","volume":"12","author":"SA Dyshlovoy","year":"2022","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:32:08Z","timestamp":1769020328000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341445"}},"subtitle":[],"editor":[{"given":"Saki","family":"Raheem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341445","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}